Marco Faustini-Fustini

Dr. Marco Faustini-Fustini


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2016 in Endocrine
Verified
Journal Article
Closed access
PDF file
ARAlberto Righi
Alberto Righi
MFMarco Faustini-Fustini
Marco Faustini-Fustini
LMLuca Morandi
Luca Morandi
VMValentina Monti
Valentina Monti
asioli Asioliasioli Asioli
asioli Asioli
MFMaria Pia Foschini
Maria Pia Foschini

1 April 2014 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
GEGiovanna Elmi
Giovanna Elmi
SZStefania Zaccaroni
Stefania Zaccaroni
VAVincenzo Arienti
Vincenzo Arienti
MFMarco Faustini-Fustini
Marco Faustini-Fustini

1 May 2012 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
MZMatteo Zoli
Matteo Zoli
MFMarco Faustini-Fustini
Marco Faustini-Fustini
DMDiego Mazzatenta
Diego Mazzatenta
EPErnesto Pasquini
Ernesto Pasquini
GFGiorgio Frank
Giorgio Frank

6 October 2026 in Operative Neurosurgery
Verified
Journal Article
Closed access
Carmine Antonio DonofrioCarmine Antonio Donofrio
Carmine Antonio Donofrio
GBGiacomo Bertazzoni
Giacomo Bertazzoni
LRLucia Riccio
Lucia Riccio
MCMarika Cominetti
Marika Cominetti
CMClaudia Lodovica Modesti
Claudia Lodovica Modesti
AFAntonio Fioravanti
Antonio Fioravanti
BACKGROUND AND OBJECTIVES: Conventional binostril endoscopic endonasal approaches (EEAs) provide optimal surgical ergonomics but are often associated with sinonasal morbidity. Conversely, mononostril approaches preserve mucosal integrity at the expense of surgical maneuverability. We hypothesized that the modified sparing binostril approach (moSBA) may provide a favorable balance between surgical exposure, ergonomics, and sinonasal preservation while maintaining flexibility for risk-adapted reconstruction. This study evaluates the feasibility and functional outcomes of this technique combined with a risk-adapted skull base reconstruction strategy. METHODS: We retrospectively reviewed 81 patients who underwent EEA or extended EEA for sellar and suprasellar lesions between 2021 and 2025. All procedures were performed combining a paraseptal and a contralateral endonasal corridor (moSBA). The risk-adapted reconstructive algorithm included type 1 (hemostatic material with free mucosal graft), type 2 (inlay fat graft with onlay nasoseptal flap), and type 3 (modified gasket-seal). Outcomes included extent of resection, complications, and 22-item Sinonasal Outcome Test (SNOT-22) assessment. RESULTS: EEAs were performed in 56 (69.1%) and extended EEAs in 25 (30.9%) patients. Intraoperative cerebrospinal fluid (CSF) leakage occurred in 48 cases (59.3%) and was graded as 1 in 12.3%, 2 in 34.6%, and 3 in 12.3%. Reconstruction types 1, 2, and 3 were used in 40.7%, 46.9%, and 12.4% of cases, respectively. Gross total resection was achieved in 72.9%. Postoperative CSF leakage occurred in 2.5%. On exploratory multivariate analysis, reconstruction complexity was independently associated with higher postoperative SNOT-22 score (B = 3.379, 95% CI: 0.827-5.930, P = .010). CONCLUSION: The moSBA appears to be a feasible and safe option for selected sellar and suprasellar lesions, providing favorable surgical and functional outcomes in this single-center experience. Although higher reconstruction complexity was independently associated with higher postoperative SNOT-22 scores, residual confounding related to surgical invasiveness, skull base defect magnitude, and intraoperative CSF leakage severity cannot be excluded.

1 December 2011 in Italian Journal of Medicine
Verified
Journal Article
Closed access
GEGiovanna Elmi
Giovanna Elmi
MFMarco Faustini-Fustini
Marco Faustini-Fustini
SZStefania Zaccaroni
Stefania Zaccaroni
RZRoberto Zoni
Roberto Zoni

18 February 2015 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
MZMatteo Zoli
Matteo Zoli
DMDiego Mazzatenta
Diego Mazzatenta
AVAdelaide Valluzzi
Adelaide Valluzzi
MFMarco Faustini-Fustini
Marco Faustini-Fustini
EPErnesto Pasquini
Ernesto Pasquini
GFGiorgio Frank
Giorgio Frank
Introduction: The advent of endoscopic endonasal technique has given a new horizon to cavernous sinus (CS) surgery. Indeed, the preliminary results reported by multiple authors along the last decade have revealed to be encouraging, showing a satisfactory tumor removal rate, endocrinological remission, and low morbidity. After 15 years of experience, we reviewed our surgical series of CS invading pituitary adenomas (PTA) to analyze the outcome of this approach in a larger surgical series with a more relevant follow-up. Patients and Methods: All consecutive patients with PTA involving the CS operated in our center from 1998 to 2013 were collected. All patients underwent preoperative baseline biohumoral assessments, visual field and acuity measurements, neurological examinations, and MRI. These examinations were repeated 3 months after surgery and then every 6 or 12 months to assess the neuroradiological and clinical outcome. During surgery, the effective intraoperative CS invasion (ICSI) was evaluated. At last follow-up, the surgical and endocrinological results were analyzed to assess the comprehensive evaluation as remission, control or no control of the tumor. Statistical analysis was performed to analyze the association between the CS invasion and comprehensive evaluation. Results: The series includes 374 patients (32% of at the entire series of PTA), underwent 393 surgical procedures, consisting in 314 midline transsphenoidal approach and 75 ethmoid-pterygo-sphenoidal approaches. The former was performed for PTA invading the medial and/or the superoinferior compartments of CS, while the latter was indicated for cases invading the anteroinferior and/or lateral compartment. Radical tumor removal was obtained in 248 cases (66.3%). Surgery permitted to achieve a complete endocrinological and tumor remission in 231 (61.8%) patients and allowed to obtain its control by other therapies in 128 cases (34.8%). Morbidity rate was of 6.6%, and the vast majority of complications resulted without any permanent sequelae. Permanent CN palsy was observed in only two cases (0.4%). At statistical analysis, the primary surgery, the lower Knosp, and ICSI scores confirmed to be associated with a more radical tumor removal (p = 0.007 and p = 0.001) and better comprehensive evaluation (p = 0.005 and p = 0.001).